March 8, 2012

BMP use up sharply, but outcomes not improved

By: OR Manager

Use of bone morphogenic protein (BMP) has risen sharply in the past decade, adding costs without evidence of better outcomes, according to a study in the February 2012 issue of Spine. BMP use rose rapidly, from 5.5% of lumbar fusions in 2003 to nearly a third (28.1%)…

Sponsored Message

You may also be interested in this session at the OR Manager Conference

Live chat by BoldChat